Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 2Neuralgia 2Neoplasms 2Chronic Pain 2Wounds and Injuries 1Peripheral Nervous System Diseases 1Pain, Intractable 1Lymphoma, Follicular 1HIV Infections 1Bronchiolitis Obliterans Syndrome 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

tetulomab tetraxetan lu-177 2Lutetium 2Isotretinoin 2ziconotide 1interferon gamma-1b 1Zidovudine 1Vinblastine 1Tumor Necrosis Factor-alpha 1Lutetium-177 1Interferon alpha-2 1Inosine Pranobex 1Fluorouracil 1Filgrastim 1Doxorubicin 1Dapsone 1Dacarbazine 1Cidofovir 1Bleomycin 1Acyclovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
AIDS-Related Complex × ziconotide × Clear all
NCT00002160 2005-06-24

A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

NIH AIDS Clinical Trials Information Service

Phase 2 Completed
100 enrolled

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Neoplasms, Pain, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡